[{"id":"8aebf424-8909-4895-a7e6-e2f46f58b8f5","acronym":"","url":"https://clinicaltrials.gov/study/NCT02642016","created_at":"2021-01-18T12:51:11.933Z","updated_at":"2024-07-02T16:36:58.921Z","phase":"Phase 1","brief_title":"A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT02642016","lead_sponsor":"Celldex Therapeutics","biomarkers":" KIT • PDGFRA","pipe":" | ","alterations":" KIT positive • PDGFRA D842V • KIT expression","tags":["KIT • PDGFRA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KIT positive • PDGFRA D842V • KIT expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CDX-0158"],"overall_status":"Completed","enrollment":" Enrollment 28","initiation":"Initiation: 12/01/2015","start_date":" 12/01/2015","primary_txt":" Primary completion: 01/30/2018","primary_completion_date":" 01/30/2018","study_txt":" Completion: 06/04/2019","study_completion_date":" 06/04/2019","last_update_posted":"2019-06-12"}]